| Title |
Bilateral Optic Neuropathy Following Phesgo Injection for HER2+ Breast Cancer |
| Creator |
John P. Thompson; Alaa N. Malik; Sidharth Puri |
| Affiliation |
Louisiana State University at New Orleans (JPT, ANM), New Orleans, Louisiana; and Ochsner Medical Center Ophthalmology (SP), New Orleans, Louisiana |
| Date |
2024-12 |
| Date Digital |
2024-12 |
| References |
Scheuer W, Friess T, Burtscher H, Bossenmaier B, Endl J, Hasmann M. Strongly enhanced antitumor activity of trastuzumab and pertuzumab combination treatment on HER2-positive human xenograft tumor models. Cancer Res. 2009;69:9330-9336. Liu CY, Francis JH, Brodie SE, et al. Retinal toxicities of cancer therapy drugs: biologics, small molecule inhibitors, and chemotherapies. Retina. 2014;34:1261-1280. Saleh M, Bourcier T, Noel G, Speeg-Schatz C, Gaucher D. Bilateral macular ischemia and severe visual loss following trastuzumab therapy. Acta Oncol. 2011;50:477-478. Rankin EM, Pitts JF. Ophthalmic toxicity during carboplatin therapy. Ann Oncol. 1993;4:337-338. Telander DG, Sarraf D. Cystoid macular edema with docetaxel chemotherapy and the fluid retention syndrome. Semin Ophthalmol. 2007;22:151-153. |
| Language |
eng |
| Format |
application/pdf |
| Type |
Text |
| Publication Type |
Journal Article |
| Source |
Journal of Neuro-Ophthalmology, December 2024, Volume; 44, Issue 4 |
| Collection |
Neuro-Ophthalmology Virtual Education Library: Journal of Neuro-Ophthalmology Archives: https://novel.utah.edu/jno/ |
| Publisher |
Lippincott, Williams & Wilkins |
| Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Rights Management |
© North American Neuro-Ophthalmology Society |
| ARK |
ark:/87278/s6mv57rd |
| Setname |
ehsl_novel_jno |
| ID |
2932932 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6mv57rd |
